Y08060

CAS No. 2222565-19-5

Y08060( Y 08060 )

Catalog No. M13549 CAS No. 2222565-19-5

Y08060 is a potent and selective BET inhibitor with Kd of 306 nM for BRD4 BD1.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Y08060
  • Note
    Research use only, not for human use.
  • Brief Description
    Y08060 is a potent and selective BET inhibitor with Kd of 306 nM for BRD4 BD1.
  • Description
    Y08060 is a potent and selective BET inhibitor with Kd of 306 nM for BRD4 BD1, displays excellent selectivity for BET subfamily over other non-BET family with the exception of moderate inhibition of CBP/EP300; esuppresses cell growth, colony formation, and expression of androgen receptor (AR), AR regulated genes, and MYC in prostate cancer cell lines. such as C4-2B, LNCaP, and 22Rv1; demonstrates good PK profile with high oral bioavailability (61.54%).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Y 08060
  • Pathway
    Chromatin/Epigenetic
  • Target
    Bromodomain
  • Recptor
    Bromodomain
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2222565-19-5
  • Formula Weight
    471.322
  • Molecular Formula
    C18H19BrN2O6S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    5-bromo-2-methoxy-N-(6-methoxy-2,2-dimethyl-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-7-yl)benzenesulfonamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Xiang Q, et al. ACS Med Chem Lett. 2018 Feb 13;9(3):262-267.
molnova catalog
related products
  • BET-BAY 002

    BET-BAY 002 is a potent BET bromodomain inhibitor; shows efficacy in a multiple myeloma model.

  • CD 161

    A potent, selective, orally bioavailable BET bromodomain inhibitor with IC50 of 7.2 and 28.2 nM for BRD4 BD2 and BRD4 BD1, respectively.

  • AU1

    AU1 (GSK 1379725A) is the first selective small molecule inhibitor of BPTF bromodomain (bromodomain PHD finger transcription factor) with Kd of 2.8 uM in a cell-based reporter assay.